Trial Profile
Relationship between the early boceprevir-S isomer plasma concentrations and the onset of breakthrough during hepatitis C virus genotype 1 triple therapy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Feb 2016
Price :
$35
*
At a glance
- Drugs Boceprevir (Primary) ; Peginterferon alfa-2a; Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Pharmacokinetics
- 04 Feb 2016 New trial record